37 employees
Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.
2014
$15M
from 2 investors over 2 rounds
Eyenovia Inc. raised $10M on November 22, 2022
Investors: Avenue Capital Group
Eyenovia Inc. raised $15M on March 4, 2022
Investors: Armistice Capital LLC